COMMUNIQUÉS West-GlobeNewswire

SPR Announces Eight Featured Posters and Presentations at NANS 2026
22/01/2026
CLEVELAND, Jan. 22, 2026 (GLOBE NEWSWIRE) -- SPR will feature eight abstracts on 60-day peripheral nerve stimulation (PNS) with SPRINT ® PNS that will be presented at the North American Neuromodulation Society (NANS) [...]
Roji Health Intelligence Re-Certified as CMS Qualified Registry for 2026
22/01/2026
CHICAGO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Roji Health Intelligence , a healthcare technology firm focused on value-based care and quality performance, today announced that it has been re-certified as a Centers for [...]
OneMedNet Real-World Data Supports FDA 510(k) Clearance of AI-Powered Scaida BrainCT-ICH Software
22/01/2026
MINNEAPOLIS, Jan. 22, 2026 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD), a leading provider of regulatory-grade, AI-ready Real-World Data (RWD), today announced that its high-quality, multimodal clinical [...]
J-Star Files Formal Complaints Against PwC with AICPA and PCAOB
22/01/2026
J-Star’s Complaints Allege PwC Misrepresented Qualifications During J-Star’s IPO, Delaying Process and Resulting in Additional Fees TAICHUNG CITY, Taiwan, Jan. 22, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. ( [...]
Kaida BioPharma Appoints Co-Founder Dr. Stella K. Vnook as Chairperson of the Board
22/01/2026
Appointment aligns Board leadership with Company’s transition to clinical-stage development and advancement of KAD-101 for platinum-resistant ovarian cancer Company advancing KAD-101, a best-in-class, next-generation [...]
Human Continuum Appoints Dr. Omar Khalid Sial, Ph.D., as its Chief Scientific Officer to Spearhead the Development of Innovative Extracellular Vesicle Topical Formulations and Advanced Biologic Therapies
22/01/2026
New York, N.Y., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”) , a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced the appointment of [...]
Privia Health to Report Fourth Quarter 2025 Results on Thursday, February 26
22/01/2026
ARLINGTON, Va., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it expects to release financial results for its fourth-quarter and twelve-month periods ended December 31, [...]
PDS Biotech Announces New U.S. Patent Covering Technology Underlying PDS0101
22/01/2026
Patent Enhances IP Estate for Lead Asset; Combined with Anticipated Biologics Exclusivity, Market Protections Extend Over 20 Years PRINCETON, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq [...]
Cannabix Marijuana Breath Test Featured on the Cover of AlcoPro’s 2026 Product Catalog
22/01/2026
VANCOUVER, British Columbia, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) a developer of marijuana and alcohol breath-testing [...]
NetraMark Engages LodeRock Advisors for Strategic Investor Relations and Capital Markets Communications Services
22/01/2026
TORONTO, Jan. 22, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials [...]
NARMAFOTINIB Large-Scale Manufactre Complete
22/01/2026
Successful completion of the first large-scale manufacture of narmafotinib which produced approx. 13 kg of drug Successful transition of process and production from an R&D facility to a commercial manufacturing [...]
What Are the Top Customer Experience Trends for 2026? New Transcom Report Identifies Five Paradoxes CX Leaders Must Address
22/01/2026
Report explains how enterprises should use AI, automation, and human expertise together to close the Experience Gap Denver CO., Jan. 22, 2026 (GLOBE NEWSWIRE) -- As enterprises evaluate how artificial intelligence will [...]
Plus Therapeutics Provides Business Update on REYOBIQ™ Clinical Program and U.S. CNSide® Commercialization
22/01/2026
Expands CNSide Clinical License in State of Pennsylvania HOUSTON, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing precision [...]
Medicus Pharma Ltd. Announces Amendment to LifeArc License Improving Teverelix® Long-Term Economic and Development Profile
22/01/2026
Amendment reduces and simplifies royalty structure on Teverelix ® from ~4% to 2% while preserving global rights and IP control The Company is developing Teverelix ® as a first in class market product for Acute Urinary [...]
Invivyd Announces Partnership with World Champion Skier Lindsey Vonn to Educate Americans on Antibodies and Disease Prevention
22/01/2026
The educational campaign will focus on teaching the American public about antibodies and preventing infectious disease The collaboration will advance public understanding of antibodies as a centerpiece of modern [...]
SweetWater Introduces Big Trip Double IPA: A Bold New Craft Beer
22/01/2026
The Daytrip IPA series grows with Big Trip - a high-ABV brew full of flavor from the Southeast’s leading craft brand ATLANTA, Jan. 22, 2026 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater Brewing” or “ [...]
Vivani Subsidiary Cortigent to Present Orion System’s Advanced Brain Implant Technology in Poster Session at NANS 2026
22/01/2026
Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new Orion cortical stimulation system for visual perception, designed to treat most common forms [...]
ProPhase Labs Uplists from Pink Sheets to OTC Market
22/01/2026
UNIONDALE, NY, Jan. 22, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (“ProPhase” or the “Company”), a diversified life sciences and diagnostics company, today announced that its common stock has been approved and [...]
Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.
22/01/2026
LAUPHEIM, Germany and MILFORD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, today announced that [...]

Pages